Cargando…
Sickle cell disease patients with COVID‐19 in Guadeloupe: Surprisingly favorable outcomes
We investigate risk factors for hospitalization and difference between sickle cell syndromes in a cohort of COVID‐19 sickle cell disease (SCD) adult patients managed in the Reference Center of Guadeloupe. We retrospectively collected data of symptomatic SCD adult patients infected with SARS‐CoV‐2 be...
Autores principales: | Bernit, Emmanuelle, Romana, Marc, Alexis‐Fardini, Scylia, Tarer, Vanessa, Roger, Pierre‐Marie, Doumdo, Lydia, Petras, Eléonore, Charneau, Corine, Tressières, Benoit, Dessources, Marie Dominique Hardy, Etienne‐Julan, Maryse |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9347453/ https://www.ncbi.nlm.nih.gov/pubmed/35935270 http://dx.doi.org/10.1002/jha2.449 |
Ejemplares similares
-
P-041: DEATH ASSOCIATED WITH DELTA VARIANT COVID-19 AMONG SICKLE CELL DISEASE ADULT PATIENTS DURING THE 2021 4TH WAVE IN GUADELOUPE
por: E., BERNIT, et al.
Publicado: (2022) -
Unmet needs in the management of immune‐mediated thrombotic thrombocytopenic purpura and the potential role of caplacizumab in the UK—A modified‐Delphi study
por: Scully, Marie, et al.
Publicado: (2022) -
Altered type 1 interferon responses in alloimmunized and nonalloimmunized patients with sickle cell disease
por: Madany, Emaan, et al.
Publicado: (2021) -
Erytra blood group analyser and kode technology testing of SARS‐CoV‐2 antibodies among convalescent patients and vaccinated individuals
por: Weinstock, Christof, et al.
Publicado: (2021) -
Paroxysmal nocturnal haemoglobinuria, diagnosis and haematological findings, first report from Iran, model for developing countries
por: Jahangirpour, Mohammadali, et al.
Publicado: (2022)